RxDoctor Payments Data

Mark Roschewski

Hematology · Washington, DCNPI 1912991951

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 3 manufacturers reported payments, led by AstraZeneca at 47.8% of the total.

$356in general payments, 2019–2025

Across 4 payments — averaging $89.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$170
  • Beigene USA, Inc.$109
  • Acerta Pharma LLC$77
$5,806,035in research payments, 2019–2025

Across 33 payments — averaging $175,940 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$1.4M
  • AbbVie$1.2M
  • Pharmacyclics LLC, An Abbvie Company$1.2M
  • Merck$948K
  • Bayer$770K
  • Adaptive Biotechnologies Corporation$238K
  • plus $54K from 2 others

What the payments were for

  • Food & beverage$356100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca2$170
Beigene USA, Inc.1$109
Acerta Pharma LLC1$77

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few hematology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Other hematology in Washington

Where these figures come from

Is this you, or does something look wrong? →